Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Phase I Randomized, Single-blind, Placebo-controlled, Single-center Study of the Effect of Postoperative Administration of Single Dose Ketamine on Pain and Recovery After Robotic Removal of Endometriosis in Patients With Chronic Pelvic Pain


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05229653

Organisation Name: NYU Langone Health

Overal Status: Recruiting

Start Date: April 12, 2022

Last Update: April 14, 2022

Lead Sponsor: NYU Langone Health

Brief Summary: This is a randomized, single blinded, placebo-controlled trial to study the effectiveness of a subanesthetic dose (0.6 mg/kg) of ketamine versus placebo (saline) on postoperative pain and pain on adult female chronic pelvic pain patients undergoing robotic removal of endometriosis. The objective of the study is to explore the effect of a sub anesthetic dose of ketamine (0.6 mg/kg) vs. saline control on postoperative pain and recovery in chronic pelvic pain patients who have undergone robotic removal of endometriosis.

Conditions:
  • Endometriosis
  • Post Operative Pain


Total execution time in seconds: 0.54653096199036